Valuation: AngioDynamics, Inc.

Market Cap 520M 464M 429M 389M 727M 49.36B 739M 5.16B 2.04B 25.86B 1.95B 1.91B 81.54B P/E 2027 *
-18.1x
P/E 2028 * -28.8x
Enterprise Value 520M 464M 429M 389M 727M 49.36B 739M 5.16B 2.04B 25.86B 1.95B 1.91B 81.54B EV / Sales 2027 *
1.54x
EV / Sales 2028 * 1.47x
Free-Float
85.66%
Yield 2027 *
-
Yield 2028 * -
1 day+2.87%
1 week+10.01%
Current month-19.60%
1 month-19.08%
3 months-9.01%
6 months+11.40%
Current year-3.70%
1 week 11.09
Extreme 11.09
12.47
1 month 10.62
Extreme 10.62
15.76
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2016
Director of Finance/CFO 51 23/10/2019
Chief Tech/Sci/R&D Officer - 01/01/2017
Director TitleAgeSince
Chairman 65 29/04/2014
Director/Board Member 68 29/01/2007
Director/Board Member 62 01/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Sell

General Counsel

-23,370 0.0565%
22/07/26 Exercice

Executive/Senior Manager

40,889 0.0990%
22/07/26 Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
+2.87%+10.01%+0.20%+86.78% 520M
+1.16%-1.13%-18.25%+9.38% 179B
+0.02%+4.24%-19.55%+15.88% 118B
-1.22%+0.70%+1.86%+32.59% 117B
+2.29%+17.36%-42.18%+8.22% 93.26B
-2.21%-2.91%-0.51%+75.12% 63.16B
-1.06%+1.75%+13.48%+74.12% 55.68B
-0.75%+3.73%+7.04%-23.26% 54.18B
-1.13%+0.00%-12.56%+30.09% 44.15B
+0.17%+5.85%-5.20%-11.43% 33.95B
Average +0.01%+4.24%-7.57%+29.75% 75.89B
Weighted average by Cap. -0.00%+3.09%-11.76%+22.03%

Financials

2027 *2028 *
Net sales 338M 302M 279M 252M 472M 32.06B 480M 3.35B 1.33B 16.8B 1.27B 1.24B 52.95B 355M 317M 293M 265M 496M 33.69B 505M 3.52B 1.39B 17.65B 1.33B 1.3B 55.65B
Net income -28.86M -25.77M -23.8M -21.57M -40.36M -2.74B -41.03M -286M -113M -1.44B -108M -106M -4.52B -18.19M -16.25M -15.01M -13.6M -25.45M -1.73B -25.87M -181M -71.5M -905M -68.27M -66.82M -2.85B
Net Debt - -
Projected Income Statement - Annual - AngioDynamics, Inc.
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
23/10/26 $12.37 +2.87% 631,326
22/10/26 $12.02 +1.09% 673,154
21/10/26 $11.89 +0.68% 725,279
20/10/26 $11.81 +3.69% 1,367,373
19/10/26 $11.39 +1.33% 875,917
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - AngioDynamics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.36USD
Average target price
19.75USD
Spread / Average Target
+59.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AngioDynamics, Inc.
  1. Stock Market
  2. Stocks
  3. ANGO Stock